Search for: "Novartis Pharmaceuticals Corp." Results 41 - 60 of 366
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Guest Post by Prof. Contreras: Rambus Redux? – Standards, Patents and Non-Disclosure in the Pharmaceutical Sector (Momenta v. Amphastar)
29 Jun 2018, 7:50 am by Jason Rantanen
  In July 2010, Momenta Pharmaceuticals, in conjunction with Novartis’s Sandoz division, received FDA approval for a biosimilar version of enoxaparin. [read post]
Patently-O - http://patentlyo.com/patent
Top 5 PTAB Related Decisions of 2017
21 Feb 2018, 7:45 pm by Scott McKeown
Torrent Pharmaceuticals (here) The PTAB’s Institution Decision in Novartis denied grounds including a prior art reference known as “Sakai. [read post]
Patents Post-Grant - http://www.patentspostgrant.com
T.H. v. Novartis Pharmaceuticals Corporation, S233898
13 Jan 2018, 8:00 pm
American Home Products Corp. [read post]
Frederic Borel - http://fredericborel.blogspot.ch/
More on Venue -- Plexxikon v. Novartis Pharmaceutical Corp. (N.D. Cal. 2017)
13 Dec 2017, 9:59 pm by Patent Docs
By Kevin E. [read post]
Patent Docs - http://www.patentdocs.org/
Conference Report: Zurich IP Retreat 2017 - Patents and Hindsight (Part I)
18 Sep 2017, 1:36 am
The first Zurich IP Retreat was held on Friday/Saturday 8/9 September 2017 on the shores of lake Zurich, organized by INGRES and ETH Zurich, in honour of Dr. [read post]
IPKat - http://ipkitten.blogspot.com/
Novartis loses IPR appeal at CAFC in Torrent case
12 Apr 2017, 9:52 am by Lawrence B. Ebert
Patent No.8,324,283 (the ’283 patent), owned by Novartis AG andMistubishi Tanabe Pharma Corp. [read post]
IPBiz - http://ipbiz.blogspot.com/
Generics Successful at Invalidating Novartis Gilenya Patent
12 Apr 2017, 8:44 am by Dennis Crouch
Mentor Graphics Corp., 814 F.3d 1309, 1322 (Fed. [read post]
Patently-O - http://patentlyo.com/patent
Novartis AG loses to Noven in appeal of PTAB written decisions
5 Apr 2017, 9:08 am by Lawrence B. Ebert
Corp. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Garlock prevails at the CAFC in Smith case, 2015-1758. WD Missouri reversed.
23 Aug 2016, 10:34 am by Lawrence B. Ebert
” Appellee Br.at 7 n.3 (citing Novartis Pharmaceuticals Corp. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Court to Weigh Brand Liability for Generic Drugs
28 Jun 2016, 9:02 am by Dean Freeman
Novartis Pharm. [read post]
South Florida Injury Lawyers Blog - http://www.southfloridainjurylawyersblog.com/
Pharmaceutical Injury Case Asks If Brand Names Can Be Sued for Generic Drugs
26 Jun 2016, 3:31 am by Law Offices of Jeffrey S. Glassman
Corp. [read post]
Product Liability Lawyer Blog - http://www.productliabilitylawyerblog.com/
Another Outlier From California On Innovator Liability
18 Mar 2016, 2:04 pm
Novartis Pharmaceuticals Corp., No. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
The Renaissance of the Learned Intermediary Rule
3 Mar 2016, 5:19 am
Novartis Pharmaceuticals Corp., 247 P.3d 244, 257 (Mont. 2010); Downing v. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Lost Chance Loses In Product Liability
30 Nov 2015, 1:25 pm
Novartis Pharmaceuticals Corp., 944 F. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Subsidiary of Global Healthcare Company Agrees to Pay $390 Million in Whistleblower's False Claims Act Suit
3 Nov 2015, 9:00 am
., Board Certified by The Florida Bar in Health Law Novartis Pharmaceuticals Corp. [read post]
The Health Law Firm Blog - http://www.thehealthlawfirm.com/blog/
Subsidiary of Global Healthcare Company Agrees to Pay $390 Million in Whistleblower's False Claims Act Suit
3 Nov 2015, 9:00 am
., Board Certified by The Florida Bar in Health Law Novartis Pharmaceuticals Corp. [read post]
The Health Law Firm Blog - http://www.thehealthlawfirm.com/blog/
Subsidiary of Global Healthcare Company Agrees to Pay $390 Million in Whistleblower's False Claims Act Suit
3 Nov 2015, 9:00 am
., Board Certified by The Florida Bar in Health Law Novartis Pharmaceuticals Corp. [read post]
The Health Law Firm Blog - http://www.thehealthlawfirm.com/blog/
First Amendment Notes: Amicus Briefs In Pacira & Application of IMS v. Sorrell
22 Oct 2015, 8:42 am
  Sorrell, of course, held that pharmaceutical promotion was First Amendment protected speech, as we discussed here. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
On Amending Rule 702 of the Federal Rules of Evidence
17 Oct 2015, 5:29 am by Schachtman
Novartis Pharms., No. 5:11–CV–680–D, 2013 WL 4854488, at *3 (Sept. 11, 2013). [read post]
Tortini - http://schachtmanlaw.com/blog/
Lack of Warning Causation Dooms Aredia-Zometa Case
14 Oct 2015, 4:30 am
Novartis Pharmaceuticals Corp., 2015 U.S. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/